A New Approach to the Development of <scp>Disease‐Modifying</scp> Therapies for <scp>PD</scp>; Fighting Another Pandemic
Karl Kieburtz(Rochester Institute of Technology), C. Warren Olanow(Icahn School of Medicine at Mount Sinai), Andrew McGarry(Cooper Medical School of Rowan University), Russell Katz
Cited by 25
Related Papers
MDS clinical diagnostic criteria for Parkinson's disease
|Movement Disorders|2015|7.4k
The Parkinson Progression Marker Initiative (PPMI)
|Progress in Neurobiology|2011|1.9k
MDS research criteria for prodromal Parkinson's disease
|Movement Disorders|2015|1.3k
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
|New England Journal of Medicine|2009|889
Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy
|Movement Disorders|2017|846